| Market Closed - Nasdaq 05:16:00 2024-06-28 pm EDT | 5-day change | 1st Jan Change | ||
| 17,733 PTS | -0.71% |
|
+0.24% | +18.13% |
| Jun. 28 | US Equity Indexes End Week Mixed as Investors Gauge Monetary Policy Direction | MT |
| Jun. 28 | Jiuzi Holdings to Implement 1-For-13 Reverse Stock Split | MT |
Jan 25 (Reuters) - CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after shares of the cancer drug developer rose 52.6% at the open on the Nasdaq.
(Reporting by Pritam Biswas in Bengaluru; Editing by Pooja Desai and Shilpi Majumdar)
Highest NASDAQ Composite increases |
|
|---|---|
| +16.85% | |
| +8.23% | |
| +8.15% | |
| +8.15% | |
| +6.96% |
The sharpest declines in NASDAQ Composite. |
|
|---|---|
| -10.63% | |
| -10.84% | |
| -11.77% | |
| -34.83% | |
| -43.97% |
NASDAQ COMPOSITE 
